Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2006-07-12

Clinical Trial Update: Safety Study of Idebenone to Treat Friedreich's Ataxia [Phase 1]

View source ↗

Summary

Notes completion of a Phase 1 safety study evaluating idebenone for Friedreich's ataxia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Idebenone (idebenone)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Friedreich Ataxia | Phase 1 | Status: COMPLETED